Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
CStone Pharmaceuticals (2616 HK)
Watchlist
89
Analysis
Health Care
•
Hong Kong
CStone Pharmaceuticals operates as a biotechnology company. The Company develops immuno-oncology and molecularly targeted drugs to address unmet medical needs for cancer patients. CStone Pharmaceuticals serves customers worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
06 May 2024 12:00
Voluntary Announcement - Cstone To Present Cs5001 (Ror1 Adc) Phase I Results At 2024 Asco Annual Meeting
Attachment
Exchange Announcement •
02 May 2024 12:08
Voluntary Announcement - Increase In Shareholding By Non-Executive Director Mr. Kenneth Walton Hitchner Iii By 2,219,500 Shares
Attachment
Exchange Announcement •
29 Apr 2024 12:00
Voluntary Announcement - Further Increase In Shareholding By Ceo And Executive Director Dr. Jianxin Yang By 3,345,000 Shares, With Accumulated Purchase Totalling 7,529,500 Shares
Attachment
Exchange Announcement •
23 Apr 2024 17:01
Environmental, Social And Governance Report 2023
Attachment
Exchange Announcement •
23 Apr 2024 17:00
2023 Annual Report
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.2
x